Search

everythinglearnresearchcommunity

for

Search:↓

The mutation causing Hutchinson-Gilford progeria syndrome leads to severe skin problems and early death in mice.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

DPCP works best for alopecia areata, but more research is needed for better treatments.

New method efficiently isolates hair growth cells from newborn mouse skin.

The method successfully isolates cells that are important for hair growth and could help study hair loss.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

PDGF signaling is crucial for maintaining and renewing hair follicle stem cells, which could help treat hair loss.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

A new mutation in the HR gene causes hair loss in a specific family.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Researchers created a reliable method to measure dexpanthenol and resorcinol in hair products.

Human dermal stem/progenitor cells can divide and differentiate more than hair follicle dermal papilla cells.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Higher DHEA-S levels in hirsute females affect hair growth phases.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Certain gene variations may increase the risk and severity of alopecia areata.

The document's conclusion cannot be provided because the document is not available or cannot be parsed.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

PHGDH promotes cancer growth by aiding cell proliferation and tumor progression.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Removing a specific gene in certain skin cells causes hair loss on the body by disrupting normal hair development.

DHT causes thicker and less elastic skin, linked to hair loss.